Document:

Exhibit 4.5

 

DESCRIPTION OF REGISTRANT’S SECURITIES

 

The following description of the securities
of Tuscan Holdings Corp. II (“Company”) is based on and qualified by the Company’s Amended and Restated Certificate
of Incorporation (the “Charter”). References to the “Company” and to “we,” “us,” and “our”
refer to Tuscan Holdings Corp. II.

 

General

 

The Company is authorized to issue 50,000,000
shares of common stock, par value $0.0001, and 1,000,000 shares of preferred stock, par value $0.0001. There are no shares of preferred
stock currently outstanding. 

 

Units

 

Composition. Each unit consists of one
share of common stock and one half of one warrant. Each whole warrant entitles the holder to purchase one share of common stock.

 

Listing. The units are listed on the Nasdaq
Capital Market under the symbol “THCAU.”

 

Common Stock

 

Authorization. The outstanding shares
of the Company’s common stock are duly authorized, validly issued, fully paid and nonassessable.

 

Listing. The Company’s common
stock is listed on the Nasdaq Capital Market under the symbol “THCA.”

 

Voting Rights. Common stockholders of
record are entitled to one vote for each share held on all matters to be voted on by stockholders. Any action required to be taken at
any annual or special meeting of stockholders, or any action which may be taken at any annual or special meeting of such stockholders,
may be taken without a meeting, without prior notice and without a vote, if a consent in writing, setting forth the action so taken,
shall be signed by the holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize
or take such action at a meeting at which all shares entitled to vote thereon were present and voted, and shall be delivered to us by
delivery to our registered office in the State of Delaware, our principal place of business, or one of our officers or agents having
custody of the book in which proceedings of meetings of stockholders are recorded. Delivery made to our registered office shall be by
hand or by certified or registered mail, return receipt requested. Prompt notice of the taking of the corporate action without a meeting
by less than unanimous written consent shall be given to those stockholders who have not consented in writing.

 

Tuscan Holdings Acquisition II LLC, our sponsor
(“Sponsor”), as well as all of our officers and directors, have agreed to vote their respective shares of common stock owned
by them immediately prior to our initial public offering (the “founder’s common stock”) and any shares purchased following
the initial public offering in the open market in favor of any proposed business combination.

 

Conversion Rights. Holders of common
stock issued in the Company’s initial public offering (which we refer to as “public shares”) have the right to demand
that the Company convert such shares into a pro rata portion of the Company’s trust account upon the consummation of our initial
business combination, either in connection with a stockholder meeting called to approve the business combination or by means of a tender
offer.

 

The decision as to whether we will seek stockholder
approval of a proposed business combination or conduct a tender offer will be made by us, solely in our discretion, and will be based
on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require us to seek stockholder
approval under the law or stock exchange listing requirement. We intend to conduct redemptions without a stockholder vote pursuant to
the tender offer rules of the Securities and Exchange Commission (“SEC”) unless stockholder approval is required by law or
stock exchange listing requirement or we choose to seek stockholder approval for business or other legal reasons.

 

If a stockholder vote is not required and we do
not decide to hold a stockholder vote for business or other legal reasons, we will, pursuant to our Charter, conduct the redemptions pursuant
to the tender offer rules of the SEC, and file tender offer documents with the SEC prior to consummating our initial business combination.
Our Charter requires these tender offer documents to contain substantially the same financial and other information about the initial
business combination and the redemption rights as is required under the SEC’s proxy rules. If, however, stockholder approval of
the transaction is required by law or Nasdaq, or we decide to obtain stockholder approval for business or other reasons, we will, like
many blank check companies, offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant
to the tender offer rules. If we seek stockholder approval, we will consummate our initial business combination only if a majority of
the outstanding shares of common stock voted are voted in favor of the business combination.

 

     

     

    

 

Outside Date. Pursuant to our Charter,
if we do not consummate an initial business combination by April 16, 2021 (unless such date is extended by our stockholders pursuant to
an amendment to our Charter), our corporate existence will cease except for the purposes of winding up our affairs and liquidating and
we will redeem 100% of our outstanding public shares for a pro rata portion of the funds held in the trust account, equal to the aggregate
amount then on deposit in the trust account including interest earned on the funds held in the trust account and not previously released
to us, divided by the number of then outstanding public shares, subject to applicable law and as further described herein. Our Sponsor,
officers, and directors have agreed to waive their rights to participate in any liquidation distribution from the trust account occurring
upon our failure to consummate an initial business combination with respect to the common stock purchased by them in private placements.
Our Sponsor, officers and directors will therefore not participate in any liquidation distribution from the trust account with respect
to such shares. They will, however, participate in any liquidation distribution from the trust account with respect to any public shares
acquired by them.

 

If we seek to amend any provisions of our Charter
that would affect our public stockholders’ ability to convert their shares in connection with a business combination or affect the
substance or timing of our obligation to redeem 100% of our public shares if we do not complete a business combination by the required
date set forth in our Charter, we will provide public stockholders with the opportunity to convert their public shares in connection with
any such vote. This conversion right shall apply in the event of the approval of any such amendment, whether proposed by our Sponsor,
any executive officer, director or director nominee, or any other person. 

 

Preemptive Rights. Our stockholders have
no conversion, preemptive or other subscription rights and there are no sinking fund or redemption provisions applicable to the shares
of common stock, except that public stockholders have the right to sell their shares to us in a tender offer or have their shares of common
stock converted to cash equal to their pro rata share of the trust account if they vote on the proposed business combination in connection
with such business combination and the business combination is completed. Public stockholders who sell or convert their stock into their
share of the trust account still have the right to exercise the warrants that they received as part of the units.

 

Dividends. We have not paid any cash dividends
on our shares of common stock to date and do not intend to pay cash dividends prior to the completion of a business combination. The payment
of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition
subsequent to completion of a business combination. The payment of any dividends subsequent to a business combination will be within the
discretion of our then board of directors. It is the present intention of our board of directors to retain all earnings, if any, for use
in our business operations and, accordingly, our board does not anticipate declaring any dividends in the foreseeable future.

 

Preferred Stock

 

There are no shares of preferred stock outstanding.
Our Charter authorizes the issuance of 1,000,000 shares of preferred stock with such designation, rights and preferences as may be
determined from time to time by our board of directors. Our board of directors is empowered, without stockholder approval, to issue preferred
stock with dividend, liquidation, conversion, voting or other rights which could adversely affect the voting power or other rights of
the holders of common stock. However, the underwriting agreement prohibits us, prior to a business combination, from issuing preferred
stock which participates in any manner in the proceeds of the trust account, or which votes as a class with the common stock on a business
combination. We may issue some or all of the preferred stock to effect a business combination. In addition, the preferred stock could
be utilized as a method of discouraging, delaying or preventing a change in control of us. Although we do not currently intend to issue
any shares of preferred stock, we cannot assure you that we will not do so in the future.

 

Warrants

 

Listing. The Company’s warrants are
listed on the Nasdaq Capital Market under the symbol “THCAW.”

 

    2

     

    

 

Exercisability. Each warrant entitles the
registered holder to purchase one share of common stock during the exercise period. No fractional shares will be issued upon exercise
of the warrants.

 

Exercise Price. $11.50 per share, subject
to adjustment.

 

The exercise price and number of shares of common
stock issuable on exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary
dividend or our recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be
adjusted for issuances of shares of common stock at a price below their respective exercise prices.

 

In addition, if (x) we issue additional shares
of common stock or equity-linked securities for capital raising purposes in connection with the closing of our initial business combination
at an issue price or effective issue price of less than $9.50 per share of common stock (with such issue price or effective issue price
to be determined in good faith by our board of directors, and in the case of any such issuance to our Sponsor, initial stockholders or
their affiliates, without taking into account any founders’ shares held by them prior to such issuance), (y) the aggregate gross
proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of
our initial business combination on the date of the consummation of our initial business combination (net of redemptions), and (z) the
Market Value is below $9.50 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of
the greater of (i) the Market Value or (ii) the price at which we issue the additional shares of common stock or equity-linked securities.
The “Market Value” for this purpose means the volume weighted average trading price of our common stock during the 20 trading
day period starting on the trading day prior to the day on which we consummate our initial business combination.

 

Exercise Period. The warrants will become
exercisable commencing 30 days after the completion of an initial business combination.  The warrants will expire five years after
the consummation of our initial business combination, at 5:00 p.m., New York time, or earlier upon our liquidation.

 

No warrants will be exercisable for cash unless
we have an effective and current registration statement covering the shares of common stock issuable upon exercise of the warrants and
a current prospectus relating to such shares of common stock. Notwithstanding the foregoing, if a registration statement covering the
shares of common stock issuable upon exercise of the public warrants is not effective within a specified period following the consummation
of our initial business combination, warrant holders may, until such time as there is an effective registration statement and during any
period when we shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the
exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another
exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. In the event of such a cashless
exercise, each holder would pay the exercise price by surrendering the warrants for that number of shares of common stock equal to the
quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the difference
between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair
market value” for this purpose will mean the average reported last sale price of the shares of common stock for the 5 trading days
ending on the trading day prior to the date of exercise. The warrants will expire on the fifth anniversary of our completion of an initial
business combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.

 

The warrants included in the units issued privately
concurrently with our IPO and additional warrants issued in such private placement (collectively the “private warrants”),
as well as any warrants we issue to our Sponsor, officers, directors or their affiliates in payment of working capital loans made to us,
will be identical to the warrants underlying the units offered in our IPO except that such warrants will be exercisable for cash or on
a cashless basis, at the holder’s option, and will not be redeemable by us, in each case so long as they are still held by our Sponsor
or its permitted transferees.

 

Redemption. We may call the warrants for
redemption (excluding the private warrants and any warrants issued to our Sponsor, initial stockholders, officers, directors or their
affiliates in payment of working capital loans made to us), in whole and not in part, at a price of $0.01 per warrant, (i) at any time
after the warrants become exercisable, (ii) upon not less than 30 days’ prior written notice of redemption to each warrant holder
after the warrants become exercisable, (iii)  if, and only if, the reported last sale price of the shares of common stock equals
or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading
days within a 30 trading day period commencing after the warrants become exercisable and ending on the third business day prior to the
notice of redemption to warrant holders, and (iv) if, and only if, there is a current registration statement in effect with respect to
the shares of common stock underlying such warrants.

 

    3

     

    

 

The right to exercise will be forfeited unless
the warrants are exercised prior to the date specified in the notice of redemption. On and after the redemption date, a record holder
of a warrant will have no further rights except to receive the redemption price for such holder’s warrant upon surrender of such
warrant.

 

If we call the warrants for redemption as described
above, our management will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.”
In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of common stock equal to
the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the difference
between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair
market value” for this purpose shall mean the average reported last sale price of the shares of common stock for the 5 trading days
ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants.

 

Fractional Shares. No fractional shares
will be issued upon exercise of the warrants. If, upon exercise of the warrants, a holder would be entitled to receive a fractional interest
in a share, we will, upon exercise, round up to the nearest whole number the number of shares of common stock to be issued to the warrant
holder.

 

Certain Provisions of the Charter and Bylaws

 

Staggered Board of Directors

 

Our board of directors is divided into three classes,
each of which will generally serve for a term of three years with only one class of directors being elected in each year. There is no
cumulative voting with respect to the election of directors, with the result that the holders of more than 50% of the shares eligible
to vote for the election of directors can elect all of the directors. As a result, in most circumstances, a person can gain control of
our board only by successfully engaging in a proxy contest at two or more annual meetings.

 

Special Meeting of Stockholders

 

Our bylaws provide that special meetings of our
stockholders may be called only by a majority vote of our board of directors, by our president or by our chairman or by our secretary
at the request in writing of stockholders owning a majority of our issued and outstanding capital stock entitled to vote.

 

Advance Notice Requirements for Stockholder
Proposals and Director Nominations

 

Our bylaws provide that stockholders seeking to
bring business before our annual meeting of stockholders, or to nominate candidates for election as directors at our annual meeting of
stockholders must provide timely notice of their intent in writing. To be timely, a stockholder’s notice will need to be delivered
to our principal executive offices not later than the close of business on the 60th day nor earlier than the close of
business on the 90th day prior to the scheduled date of the annual meeting of stockholders. In the event that less than
70 days’ notice or prior public disclosure of the date of the annual meeting of stockholders is given, a stockholder’s notice
shall be timely if delivered to our principal executive offices not later than the 10th day following the day on which
public announcement of the date of our annual meeting of stockholders is first made or sent by us. Our bylaws also specify certain requirements
as to the form and content of a stockholders’ meeting. These provisions may preclude our stockholders from bringing matters before
our annual meeting of stockholders or from making nominations for directors at our annual meeting of stockholders.

 

    4

     

    

 

Authorized but Unissued Shares

 

Our authorized but unissued common stock and preferred
stock are available for future issuances without stockholder approval and could be utilized for a variety of corporate purposes, including
future offerings to raise additional capital, acquisitions and employee benefit plans. The existence of authorized but unissued and unreserved
common stock and preferred stock could render more difficult or discourage an attempt to obtain control of us by means of a proxy contest,
tender offer, merger or otherwise.

 

Exclusive Forum Selection

 

Our Amended and Restated Charter requires, to
the fullest extent permitted by law, that derivative actions brought in our name, actions against directors, officers and employees for
breach of fiduciary duty and other similar actions may be brought only in the Court of Chancery in the State of Delaware, except any action
(A) as to which the Court of Chancery in the State of Delaware determines that there is an indispensable party not subject to the jurisdiction
of the Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within ten
days following such determination), (B) which is vested in the exclusive jurisdiction of a court or forum other than the Court of Chancery,
(C) for which the Court of Chancery does not have subject matter jurisdiction or (D) any action arising under the Securities Act, as to
which the Court of Chancery and the federal district court for the District of Delaware shall have concurrent jurisdiction. If an action
is brought outside of Delaware, the stockholder bringing the suit will be deemed to have consented to service of process on such stockholder’s
counsel. Although we believe this provision benefits us by providing increased consistency in the application of Delaware law in the types
of lawsuits to which it applies, a court may determine that this provision is unenforceable, and to the extent it is enforceable, the
provision may have the effect of discouraging lawsuits against our directors and officers, although our stockholders will not be deemed
to have waived our compliance with federal securities laws and the rules and regulations thereunder and therefore bring a claim in another
appropriate forum. Additionally, we cannot be certain that a court will decide that this provision is either applicable or enforceable,
and if a court were to find the choice of forum provision contained in our amended and restated certificate of incorporation to be inapplicable
or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could
harm our business, operating results and financial condition.

 

Our Amended and Restated Charter provides that
the exclusive forum provision will be applicable to the fullest extent permitted by applicable law. Section 27 of the Exchange Act creates
exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations
thereunder. As a result, the exclusive forum provision will not apply to suits brought to enforce any duty or liability created by the
Exchange Act or any other claim for which the federal courts have exclusive jurisdiction.

 

Certain Anti-Takeover Provisions of Delaware
Law

 

We will be subject to the provisions of Section
203 of the Delaware General Corporation Law regulating corporate takeovers upon completion of this offering. This statute prevents certain
Delaware corporations, under certain circumstances, from engaging in a “business combination” with:

 

	 	●	a stockholder who owns 15% or more of our outstanding voting stock (otherwise known as an “interested stockholder”);

 

	 	●	an affiliate of an interested stockholder; or

 

	 	●	an associate of an interested stockholder, for three years following the date that the stockholder became an interested stockholder.

 

A “business combination” includes
a merger or sale of more than 10% of our assets. However, the above provisions of Section 203 do not apply if:

 

	 	●	our board of directors approves the transaction that made the stockholder an “interested stockholder,” prior to the date of the transaction;

 

	 	●	after the completion of the transaction that resulted in the stockholder becoming an interested stockholder, that stockholder owned at least 85% of our voting stock outstanding at the time the transaction commenced, other than statutorily excluded shares of common stock; or

 

	 	●	on or subsequent to the date of the transaction, the business combination is approved by our board of directors and authorized at a meeting of our stockholders, and not by written consent, by an affirmative vote of at least two-thirds of the outstanding voting stock not owned by the interested stockholder.

 

 

5EXHIBIT 4.5

     

    DESCRIPTION OF SECURITIES

     

    As of December 31, 2021, Ross Acquisition Corp. II (“we,” “us”, “our” or the “Company”) had the following three classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the
      “Exchange Act”): (i) its Class A ordinary shares, $0.0001 par value per share (“Class A ordinary shares”), (ii) its warrants, exercisable for one Class A ordinary share for $11.50 per share, and (iii) its units, consisting of one Class A ordinary
      share and one-third of one redeemable warrant to purchase one Class A ordinary share. References to our “sponsor” refer to Ross Holding Company LLC. The following description of our securities is not complete and may not contain all the information
      you should consider before investing in our securities. This description is summarized from, and qualified in its entirety by reference to, our amended and restated memorandum and articles of association (our “Memorandum and Articles of Association”)
      and the warrant agreement, by and among the Company and Continental Stock Transfer & Trust Company, dated as of March 16, 2021 (the “Warrant Agreement”), which are incorporated herein by reference and filed as exhibits to our Annual Report on
      Form 10-K for the year ended December 31, 2021 (the “Annual Report”), and applicable Cayman Islands law. Any terms used but not defined herein shall have the meanings ascribed to such terms in the Annual Report.

     

    General

     

    Pursuant to our Memorandum and Articles of Association, the Company is authorized to issue 500,000,000 Class A ordinary shares and 50,000,000 Class B ordinary shares, par value $0.0001 per share (“Class B ordinary
      shares”, or “founder shares”), as well as 1,000,000 preference shares, $0.0001 par value each.

     

    Units

     

    Each unit had an offering price of $10.00 and consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a
      price of $11.50 per share, subject to adjustment as described herein. Pursuant to the Warrant Agreement, a warrant holder may exercise its warrants only for a whole number of Class A ordinary shares. This means only a whole warrant may be exercised
      at any given time by a warrant holder.

     

    The Class A ordinary shares and warrants comprising the units began separate trading on May 3, 2021. Holders have the option to continue to hold units or separate their units into the component securities. Holders will
      need to have their brokers contact our transfer agent in order to separate the units into Class A ordinary shares and warrants. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Accordingly, unless
      you purchase at least three units, you will not be able to receive or trade a whole warrant.

     

    Additionally, the units will automatically separate into their component parts and will not be traded after completion of our initial business combination.

     

    Ordinary Shares

     

    Upon the closing of our initial public offering, 43,125,000 of our ordinary shares were outstanding including:

     

    	

          	•	
            34,500,000 Class A ordinary shares underlying the units issued as part of our initial public offering; and

          

     

    	

          	•	
            8,625,000 Class B ordinary shares held by our sponsor.

          

     

    
      
        

    

    Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Except as described below, holders of Class A ordinary shares and holders of Class B ordinary
      shares will vote together as a single class on all matters submitted to a vote of our shareholders except as required by law. Unless specified in our Memorandum and Articles of Association, or as required by applicable provisions of the Companies Act
      or applicable stock exchange rules, the affirmative vote of a majority of our ordinary shares that are voted is required to approve any such matter voted on by our shareholders. Approval of certain actions will require a special resolution under
      Cayman Islands law, being the affirmative vote of at least two-thirds of our ordinary shares that are voted, and pursuant to our Memorandum and Articles of Association; such actions include amending our Memorandum and Articles of Association and
      approving a statutory merger or consolidation with another company. Our board of directors is divided into three classes, each of which will generally serve for a term of three years with only one class of directors being elected in each year. There
      is no cumulative voting with respect to the election of directors, with the result that the holders of more than 50% of the shares voted for the election of directors can elect all of the directors. Our shareholders are entitled to receive ratable
      dividends when, as and if declared by the board of directors out of funds legally available therefor. In connection with our initial business combination the Company may enter into an agreement or other arrangement with the shareholders of the target
      with respect to voting and other corporate governance matters following completion of our initial business combination, and such agreement or arrangement may provide for, or the target shareholders may require that such agreement provide for,
      nomination, designation or representation rights on the board of directors of the combined entity that may not be proportionate to our shareholders’ or such target shareholders’ ownership interest in the combined company. Prior to our initial
      business combination, only holders of our founder shares have the right to vote on the election of directors. Holders of our public shares are not entitled to vote on the election of directors during such time. In addition, prior to the completion of
      an initial business combination, holders of a majority of our founder shares may remove a member of the board of directors for any reason. The provisions of our Memorandum and Articles of Association governing the appointment or removal of directors
      prior to our initial business combination may only be amended by a special resolution passed by not less than two-thirds of our ordinary shares who attend and vote at our shareholder meeting which shall include the affirmative vote of a simple
      majority of our Class B ordinary shares.

     

    Because our Memorandum and Articles of Association authorizes the issuance of up to 500,000,000 Class A ordinary shares, if the Company were to enter into a business combination, the Company may (depending on the terms
      of such a business combination) be required to increase the number of Class A ordinary shares which the Company will be authorized to issue at the same time as our shareholders vote on the business combination to the extent the Company seeks
      shareholder approval in connection with our initial business combination.

     

    In accordance with the NYSE corporate governance requirements, the Company is not required to hold an annual meeting until one year after our first fiscal year end following our listing on the NYSE. There is no
      requirement under the Companies Act for the Company to hold annual or shareholder meetings to elect directors. The Company may not hold an annual meeting of shareholders to elect new directors prior to the consummation of our initial business
      combination. Prior to the completion of an initial business combination, any vacancy on the board of directors may be filled by a nominee chosen by holders of a majority of our founder shares. In addition, prior to the completion of an initial
      business combination, holders of a majority of our founder shares may remove a member of the board of directors for any reason.

     

    
      
        

    

    The Company will provide our public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of our initial business combination at a per-share price, payable in cash, equal
      to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of our initial business combination, including interest earned on the funds held in the trust account and not previously
      released to the Company to pay our income taxes, if any, divided by the number of the then-outstanding public shares, subject to the limitations described herein. The amount in the trust account is initially anticipated to be $10.00 per public share.
      The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters. The redemption rights will include the requirement
      that a beneficial owner must identify itself in order to valid redeem its shares. Our sponsor and each member of our management team have entered into an agreement with us, pursuant to which they have agreed to waive their redemption rights with
      respect to any founder shares and public shares held by them in connection with (i) the completion of our initial business combination and (ii) a shareholder vote to approve an amendment to our Memorandum and Articles of Association (A) that would
      modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if the Company does
      not complete our initial business combination within 24 months from the closing of our initial public offering or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares or pre-initial business
      combination activity. Unlike many blank check companies that hold shareholder votes and conduct proxy solicitations in conjunction with their initial business combinations and provide for related redemptions of public shares for cash upon completion
      of such initial business combinations even when a vote is not required by law, if a shareholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or
      other reasons, the Company will, pursuant to our Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the SEC, and file tender offer documents with the SEC prior to completing our initial business
      combination. Our Memorandum and Articles of Association requires these tender offer documents to contain substantially the same financial and other information about our initial business combination and the redemption rights as is required under the
      SEC’s proxy rules. If, however, a shareholder approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain shareholder approval for business or other reasons, the Company will,
      like many blank check companies, offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval, the Company will complete our initial
      business combination only if a majority of the ordinary shares, represented in person or by proxy and entitled to vote thereon, voted at a shareholder meeting are voted in favor of the business combination. However, the participation of our sponsor,
      officers, directors, advisors or their affiliates in privately-negotiated transactions (as described in our initial public offering), if any, could result in the approval of our initial business combination even if a majority of our public
      shareholders vote, or indicate their intention to vote, against such initial business combination. For purposes of seeking approval of the majority of our issued and outstanding ordinary shares, non-votes will have no effect on the approval of our
      initial business combination once a quorum is obtained. Our Memorandum and Articles of Association requires that at least five days’ notice will be given of any shareholder meeting.

     

    If the Company seeks shareholder approval of our initial business combination and the Company does not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our
      Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the
      Exchange Act), will be restricted from redeeming its shares with respect to Excess Shares, without our prior consent. However, the Company would not be restricting our shareholders’ ability to vote all of their shares (including Excess Shares) for or
      against our initial business combination. Our shareholders’ inability to redeem the Excess Shares reduces their influence over our ability to complete our initial business combination, and such shareholders could suffer a material loss in their
      investment if they sell such Excess Shares on the open market. Additionally, such shareholders will not receive redemption distributions with respect to the Excess Shares if the Company completes its initial business combination. And, as a result,
      such shareholders will continue to hold that number of shares exceeding 15% and, in order to dispose such shares would be required to sell their shares in open market transactions, potentially at a loss.

     

    If the Company seeks shareholder approval, the Company will complete our initial business combination only if a majority of the ordinary shares, represented in person or by proxy and entitled to vote thereon, voted at a
      shareholder meeting are voted in favor of the business combination. In such case, our sponsor and each member of our management team have agreed to vote their founder shares and public shares in favor of our initial business combination.
      Additionally, each public shareholder may elect to redeem their public shares irrespective of whether they vote for or against the proposed transaction or vote at all.

     

    Pursuant to our Memorandum and Articles of Association, if the Company has not consummated an initial business combination within 24 months from the closing of our initial public offering, the Company will (i) cease all
      operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in
      the trust account, including interest earned on the funds held in the trust account and not previously released to the Company to pay our income taxes, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the
      then-outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following
      such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to our obligations under Cayman Islands law to provide for claims of creditors
      and the requirements of other applicable law. Our sponsor  and each member of our management team have entered into an agreement with us, pursuant to which they have agreed to waive their rights to liquidating distributions from the trust account
      with respect to any founder shares they hold if the Company fail to consummate an initial business combination within 24 months from the closing of our initial public offering (although they will be entitled to liquidating distributions from the
      trust account with respect to any public shares they hold if the Company fail to complete our initial business combination within the prescribed time frame). Our Memorandum and Articles of Association provides that, if the Company winds up for any
      other reason prior to the consummation of our initial business combination, the Company will follow the foregoing procedures with respect to the liquidation of the trust account as promptly as reasonably possible but not more than ten business days
      thereafter, subject to applicable Cayman Islands law.

     

    
      
        

    

    In the event of a liquidation, dissolution or winding up of the Company after a business combination, our shareholders are entitled to share ratably in all assets remaining available for distribution to them after
      payment of liabilities and after provision is made for each class of shares, if any, having preference over the ordinary shares. Our shareholders have no preemptive or other subscription rights. There are no sinking fund provisions applicable to the
      ordinary shares, except that the Company will provide our public shareholders with the opportunity to redeem their public shares for cash at a per share price equal to the aggregate amount then on deposit in the trust account, including interest
      earned on the funds held in the trust account and not previously released to the Company to pay our income taxes, if any, divided by the number of the then-outstanding public shares, upon the completion of our initial business combination, subject to
      the limitations described herein.

     

    Founder Shares

     

    The founder shares are designated as Class B ordinary shares and, except as described below, are identical to the Class A ordinary shares included in the units being sold in our initial public offering, and holders of
      founder shares have the same shareholder rights as public shareholders, except that: (a) prior to our initial business combination, only holders of the founder shares have the right to vote on the election of directors and holders of a majority of
      our founder shares may remove a member of the board of directors for any reason; (b) the founder shares are subject to certain transfer restrictions, as described in more detail below; (c) our sponsor and each member of our management team have
      entered into an agreement with us, pursuant to which they have agreed to (i) waive their redemption rights with respect to their founder shares (ii) to waive their redemption rights with respect to their founder shares and public shares in connection
      with a shareholder vote to approve an amendment to our Memorandum and Articles of Association (A) that would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in
      connection with our initial business combination or to redeem 100% of our public shares if the Company does not complete our initial business combination within 24 months from the closing of our initial public offering or (B) with respect to any
      other provision relating to the rights of holders of our Class A ordinary shares or pre-initial business combination activity; and (iii) waive their rights to liquidating distributions from the trust account with respect to any founder shares they
      hold if the Company fails to consummate an initial business combination within 24 months from the closing of our initial public offering (although they will be entitled to liquidating distributions from the trust account with respect to any public
      shares they hold if the Company fails to complete our initial business combination within the prescribed time frame); (d) the founder shares will automatically convert into our Class A ordinary shares at the time of our initial business combination
      or earlier at the option of the holders thereof as described herein; and (e) the founder shares are entitled to registration rights. If the Company seeks shareholder approval, the Company will complete its initial business combination only if a
      majority of the ordinary shares, represented in person or by proxy and entitled to vote thereon, voted at a shareholder meeting are voted in favor of the business combination. In such case, our sponsor and each member of our management team have
      agreed to vote their founder shares and public shares in favor of our initial business combination.

     

    The founder shares are designated as Class B ordinary shares and will automatically convert into Class A ordinary shares (which such Class A ordinary shares delivered upon conversion will not have redemption rights or be
      entitled to liquidating distributions from the trust account if we do not consummate an initial business combination) at the time of our initial business combination or earlier at the option of the holders thereof at a ratio such that the number of
      Class A ordinary shares issuable upon conversion of all founder shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of our initial public
      offering, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the
      consummation of our initial business combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in our initial
      business combination and any private placement warrants issued to our sponsor, its affiliates or any member of our management team upon conversion of working capital loans. In no event will the Class B ordinary shares convert into Class A ordinary
      shares at a rate of less than one-to-one.

     

    
      
        

    

    Except as described herein, our sponsor and our directors and executive officers have agreed not to transfer, assign or sell any of their founder shares until earliest of (A) one year after the completion of our initial
      business combination and (B) subsequent to our initial business combination, (x) if the closing price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations,
      recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or
      other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. The Company refers to such transfer restrictions throughout our initial public
      offering as the lock-up. Any permitted transferees would be subject to the same restrictions and other agreements of our sponsor and our directors and executive officers with respect to any founder shares.

     

    Prior to our initial business combination, only holders of our founder shares will have the right to vote on the election of directors. Holders of our public shares will not be entitled to vote on the election of
      directors during such time. In addition, prior to the completion of an initial business combination, holders of a majority of our founder shares may remove a member of the board of directors for any reason. These provisions of our Memorandum and
      Articles of Association may only be amended by a special resolution passed by not less than two-thirds of our ordinary shares who attend and vote at our shareholder meeting which shall include the affirmative vote of a simple majority of our Class B
      ordinary shares. With respect to any other matter submitted to a vote of our shareholders, including any vote in connection with our initial business combination, except as required by law, holders of our founder shares and holders of our public
      shares will vote together as a single class, with each share entitling the holder to one vote.

     

    Preference Shares

     

    Our Memorandum and Articles of Association authorizes 1,000,000 preference shares and provide that preference shares may be issued from time to time in one or more series. Our board of directors is authorized to fix the
      voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. Our board of directors is
      able to, without shareholder approval, issue preference shares with voting and other rights that could adversely affect the voting power and other rights of the holders of the ordinary shares and could have anti-takeover effects. The ability of our
      board of directors to issue preference shares without shareholder approval could have the effect of delaying, deferring or preventing a change of control of the Company or the removal of existing management. The Company has no preference shares
      issued and outstanding at the date hereof.

     

    Warrants

     

    Public Shareholders’ Warrants

     

    Each whole warrant entitles the registered holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing on the later of one year from the
      closing of our initial public offering and 30 days after the completion of our initial business combination, except as discussed in the immediately succeeding paragraph. Pursuant to the Warrant Agreement, a warrant holder may exercise its warrants
      only for a whole number of Class A ordinary shares. This means only a whole warrant may be exercised at a given time by a warrant holder. No fractional warrants will be issued upon separation of the units and only whole warrants will trade.
      Accordingly, unless you purchase at least three units, you will not be able to receive or trade a whole warrant. The warrants will expire five years after the completion of our initial business combination, at 5:00 p.m., New York City time, or
      earlier upon redemption or liquidation.

     

    
      
        

    

    The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the
      Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying the its obligations described below with respect to registration, or
      a valid exemption from registration is available. No warrant will be exercisable and the Company will not be obligated to issue a Class A ordinary share upon exercise of a warrant unless the Class A ordinary share issuable upon such warrant exercise
      has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with
      respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In no event will the Company be required to net cash settle any warrant. In the event that a
      registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the Class A ordinary share underlying such unit.

     

    The Company has agreed that as soon as practicable, but in no event later than twenty business days after the closing of our initial business combination, the Company will use its commercially reasonable efforts to file
      with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become
      effective within 60 business days after the closing of our initial business combination, and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the warrants expire or
      are redeemed, as specified in the Warrant Agreement; provided that if our Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security”
      under Section 18(b)(1) of the Securities Act, the Company may, at our option, require holders of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the
      Company so elects, the Company will not be required to file or maintain in effect a registration statement, but the Company will use our commercially reasonably efforts to register or qualify the shares under applicable blue sky laws to the extent an
      exemption is not available. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of our initial business combination, warrant holders may, until
      such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the
      Securities Act or another exemption, but the Company will use its commercially reasonably efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. In such event, each holder would pay the
      exercise price by surrendering the warrants for that number of Class A ordinary shares equal to the lesser of (A) the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants, multiplied by the
      excess of the “fair market value” (defined below) less the exercise price of the warrants by (y) the fair market value and (B) 0.361. The “fair market value” as used in this paragraph shall mean the volume weighted average price of the Class A
      ordinary shares for the ten trading days ending on the trading day prior to the date on which the notice of exercise is received by the warrant agent.

     

    Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00.

     

    Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the private placement warrants):

     

    	

          	•	
            in whole and not in part;

          

     

    	

          	•	
            at a price of $0.01 per warrant;

          

     

    	

          	•	
            upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and

          

     

    	

          	•	
            if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the
              heading “—Warrants—Public Shareholders’ Warrants—Anti-Dilution Adjustments”) for any 20 trading days within a 30-trading day period ending three trading days before the Company send the notice of
              redemption to the warrant holders.

          

     

    
      
        

    

    The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then
      effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption period. If and when the warrants become redeemable, the Company may exercise its redemption right even if the Company is unable
      to register or qualify the underlying securities for sale under all applicable state securities laws.

     

    The Company has established the last of the redemption criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the warrant exercise price. If the foregoing
      conditions are satisfied and the Company issue a notice of redemption of the warrants, each warrant holder will be entitled to exercise his, her or its warrant prior to the scheduled redemption date. However, the price of the Class A ordinary shares
      may fall below the $18.00 redemption trigger price (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “—Warrants—Public
        Shareholders’ Warrants—Anti-Dilution Adjustments”) as well as the $11.50 (for whole shares) warrant exercise price after the redemption notice is issued.

     

    Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00.

     

    Once the warrants become exercisable, the Company may redeem the outstanding warrants:

     

    	

          	•	
            in whole and not in part;

          

     

    	

          	•	
            at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by
              reference to the table below, based on the redemption date and the “fair market value” of Class A ordinary shares (as defined below) except as otherwise described below;

          

     

    	

          	•	
            if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the
              heading “—Warrants—Public Shareholders’ Warrants—Anti-Dilution Adjustments”) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of
              redemption to the warrant holders; and

          

     

    	

          	•	
            if the closing price of the Class A ordinary shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less
              than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “—Warrants—Public Shareholders’
                Warrants—Anti-Dilution Adjustments”), the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above.

          

     

    Beginning on the date the notice of redemption is given until the warrants are redeemed or exercised, holders may elect to exercise their warrants on a cashless basis. The numbers in the table below represent the number
      of Class A ordinary shares that a warrant holder will receive upon such cashless exercise in connection with a redemption by the Company pursuant to this redemption feature, based on the “fair market value” of Class A ordinary shares on the
      corresponding redemption date (assuming holders elect to exercise their warrants and such warrants are not redeemed for $0.10 per warrant), determined for these purposes based on volume weighted average price of the Class A ordinary shares during the
      ten trading days immediately following the date on which the notice of redemption is sent to the holders of warrants, and the number of months that the corresponding redemption date precedes the expiration date of the warrants, each as set forth in
      the table below. The Company will provide its warrant holders with the final fair market value no later than one business day after the 10-trading day period described above ends.

     

    Pursuant to the Warrant Agreement, references above to Class A ordinary shares shall include a security other than Class A ordinary shares into which the Class A ordinary shares have been converted or exchanged for in
      the event the Company is not the surviving company in our initial business combination. The numbers in the table below will not be adjusted when determining the number of Class A ordinary shares to be issued upon exercise of the warrants if the
      Company is not the surviving entity following our initial business combination.

     

    
      
        

    

    The share prices set forth in the column headings of the table below will be adjusted as of any date on which the number of shares issuable upon exercise of a warrant or the exercise price of a warrant is adjusted as set
      forth under the heading “—Anti-dilution Adjustments” below. If the number of shares issuable upon exercise of a warrant is adjusted, the adjusted share prices in the column headings will equal the share
      prices immediately prior to such adjustment, multiplied by a fraction, the numerator of which is the number of shares deliverable upon exercise of a warrant immediately prior to such adjustment and the denominator of which is the number of shares
      deliverable upon exercise of a warrant as so adjusted. In such an event, the number of shares in the table below shall be adjusted by multiplying such share amounts by a fraction, the numerator of which is the number of shares deliverable upon
      exercise of a warrant immediately prior to such adjustment and the denominator of which is the number of shares deliverable upon exercise of a warrant as so adjusted. If the exercise price of a warrant is adjusted, (a) in the case of an adjustment
      pursuant to the fifth paragraph under the heading “—Anti-dilution Adjustments” below, the adjusted share prices in the column headings will equal the unadjusted share price multiplied by a fraction, the
      numerator of which is the higher of the Market Value and the Newly Issued Price as set forth under the heading “—Anti-dilution Adjustments” and the denominator of which is $10.00 and (b) in the case of an
      adjustment pursuant to the second paragraph under the heading “—Anti-dilution Adjustments” below, the adjusted share prices in the column headings will equal the unadjusted share price less the decrease in the
      exercise price of a warrant pursuant to such exercise price adjustment.

     

    
      	
              Redemption Date

            	 	
              Fair Market Value of Class A Ordinary Shares

            	 
	
              (period to expiration of warrants)

            	 	
              ≤$10.00

            	
              ​

            	
              11.00

            	 	
              12.00

            	 	
              13.00

            	
              ​

            	
              14.00

            	 	
              15.00

            	 	
              16.00

            	 	
              17.00

            	
              ​

            	
              ≥18.00

            	 
	
              60 months

            	 	
              0.261

            	
              ​

            	
              0.281

            	 	
              0.297

            	 	
              0.311

            	
              ​

            	
              0.324

            	 	
              0.337

            	 	
              0.348

            	 	
              0.358

            	
              ​

            	
              0.361

            	 
	
              57 months

            	 	
              0.257

            	
              ​

            	
              0.277

            	 	
              0.294

            	 	
              0.310

            	
              ​

            	
              0.324

            	 	
              0.337

            	 	
              0.348

            	 	
              0.358

            	
              ​

            	
              0.361

            	 
	
              54 months

            	 	
              0.252

            	
              ​

            	
              0.272

            	 	
              0.291

            	 	
              0.307

            	
              ​

            	
              0.322

            	 	
              0.335

            	 	
              0.347

            	 	
              0.357

            	
              ​

            	
              0.361

            	 
	
              51 months

            	 	
              0.246

            	
              ​

            	
              0.268

            	 	
              0.287

            	 	
              0.304

            	
              ​

            	
              0.320

            	 	
              0.333

            	 	
              0.346

            	 	
              0.357

            	
              ​

            	
              0.361

            	 
	
              48 months

            	 	
              0.241

            	
              ​

            	
              0.263

            	 	
              0.283

            	 	
              0.301

            	
              ​

            	
              0.317

            	 	
              0.332

            	 	
              0.344

            	 	
              0.356

            	
              ​

            	
              0.361

            	 
	
              45 months

            	 	
              0.235

            	
              ​

            	
              0.258

            	 	
              0.279

            	 	
              0.298

            	
              ​

            	
              0.315

            	 	
              0.330

            	 	
              0.343

            	 	
              0.356

            	
              ​

            	
              0.361

            	 
	
              42 months

            	 	
              0.228

            	
              ​

            	
              0.252

            	 	
              0.274

            	 	
              0.294

            	
              ​

            	
              0.312

            	 	
              0.328

            	 	
              0.342

            	 	
              0.355

            	
              ​

            	
              0.361

            	 
	
              39 months

            	 	
              0.221

            	
              ​

            	
              0.246

            	 	
              0.269

            	 	
              0.290

            	
              ​

            	
              0.309

            	 	
              0.325

            	 	
              0.340

            	 	
              0.354

            	
              ​

            	
              0.361

            	 
	
              36 months

            	 	
              0.213

            	
              ​

            	
              0.239

            	 	
              0.263

            	 	
              0.285

            	
              ​

            	
              0.305

            	 	
              0.323

            	 	
              0.339

            	 	
              0.353

            	
              ​

            	
              0.361

            	 
	
              33 months

            	 	
              0.205

            	
              ​

            	
              0.232

            	 	
              0.257

            	 	
              0.280

            	
              ​

            	
              0.301

            	 	
              0.320

            	 	
              0.337

            	 	
              0.352

            	
              ​

            	
              0.361

            	 
	
              30 months

            	 	
              0.196

            	
              ​

            	
              0.224

            	 	
              0.250

            	 	
              0.274

            	
              ​

            	
              0.297

            	 	
              0.316

            	 	
              0.335

            	 	
              0.351

            	
              ​

            	
              0.361

            	 
	
              27 months

            	 	
              0.185

            	
              ​

            	
              0.214

            	 	
              0.242

            	 	
              0.268

            	
              ​

            	
              0.291

            	 	
              0.313

            	 	
              0.332

            	 	
              0.350

            	
              ​

            	
              0.361

            	 
	
              24 months

            	 	
              0.173

            	
              ​

            	
              0.204

            	 	
              0.233

            	 	
              0.260

            	
              ​

            	
              0.285

            	 	
              0.308

            	 	
              0.329

            	 	
              0.348

            	
              ​

            	
              0.361

            	 
	
              21 months

            	 	
              0.161

            	
              ​

            	
              0.193

            	 	
              0.223

            	 	
              0.252

            	
              ​

            	
              0.279

            	 	
              0.304

            	 	
              0.326

            	 	
              0.347

            	
              ​

            	
              0.361

            	 
	
              18 months

            	 	
              0.146

            	
              ​

            	
              0.179

            	 	
              0.211

            	 	
              0.242

            	
              ​

            	
              0.271

            	 	
              0.298

            	 	
              0.322

            	 	
              0.345

            	
              ​

            	
              0.361

            	 
	
              15 months

            	 	
              0.130

            	
              ​

            	
              0.164

            	 	
              0.197

            	 	
              0.230

            	
              ​

            	
              0.262

            	 	
              0.291

            	 	
              0.317

            	 	
              0.342

            	
              ​

            	
              0.361

            	 
	
              12 months

            	 	
              0.111

            	
              ​

            	
              0.146

            	 	
              0.181

            	 	
              0.216

            	
              ​

            	
              0.250

            	 	
              0.282

            	 	
              0.312

            	 	
              0.339

            	
              ​

            	
              0.361

            	 
	
              9 months

            	 	
              0.090

            	
              ​

            	
              0.125

            	 	
              0.162

            	 	
              0.199

            	
              ​

            	
              0.237

            	 	
              0.272

            	 	
              0.305

            	 	
              0.336

            	
              ​

            	
              0.361

            	 
	
              6 months

            	 	
              0.065

            	
              ​

            	
              0.099

            	 	
              0.137

            	 	
              0.178

            	
              ​

            	
              0.219

            	 	
              0.259

            	 	
              0.296

            	 	
              0.331

            	
              ​

            	
              0.361

            	 
	
              3 months

            	 	
              0.034

            	
              ​

            	
              0.065

            	 	
              0.104

            	 	
              0.150

            	
              ​

            	
              0.197

            	 	
              0.243

            	 	
              0.286

            	 	
              0.326

            	
              ​

            	
              0.361

            	 
	
              0 months

            	 	
              —

            	
              ​

            	
              —

            	 	
              0.042

            	 	
              0.115

            	
              ​

            	
              0.179

            	 	
              0.233

            	 	
              0.281

            	 	
              0.323

            	
              ​

            	
              0.361

            	 

       

      

    

    
      
        

    

    The exact fair market value and redemption date may not be set forth in the table above, in which case, if the fair market value is between two values in the table or the redemption date is between two redemption dates
      in the table, the number of Class A ordinary shares to be issued for each warrant exercised will be determined by a straight-line interpolation between the number of shares set forth for the higher and lower fair market values and the earlier and
      later redemption dates, as applicable, based on a 365 or 366-day year, as applicable. For example, if the volume weighted average price of the Class A ordinary shares during the ten trading days immediately following the date on which the notice of
      redemption is sent to the holders of the warrants is $11.00 per share, and at such time there are 57 months until the expiration of the warrants, holders may choose to, in connection with this redemption feature, exercise their warrants for 0.277
      Class A ordinary shares for each whole warrant. For an example where the exact fair market value and redemption date are not as set forth in the table above, if the volume weighted average price of the Class A ordinary shares during the ten trading
      days immediately following the date on which the notice of redemption is sent to the holders of the warrants is $13.50 per share, and at such time there are 38 months until the expiration of the warrants, holders may choose to, in connection with
      this redemption feature, exercise their warrants for 0.298 Class A ordinary shares for each whole warrant. In no event will the warrants be exercisable on a cashless basis in connection with this redemption feature for more than 0.361 Class A
      ordinary shares per warrant (subject to adjustment). Finally, as reflected in the table above, if the warrants are out of the money and about to expire, they cannot be exercised on a cashless basis in connection with a redemption by the Company
      pursuant to this redemption feature, since they will not be exercisable for any Class A ordinary shares.

     

    This redemption feature differs from the typical warrant redemption features used in many other blank check offerings, which typically only provide for a redemption of warrants for cash (other than the private placement
      warrants) when the trading price for the Class A ordinary shares exceeds $18.00 per share for a specified period of time. This redemption feature is structured to allow for all of the outstanding warrants to be redeemed when the Class A ordinary
      shares are trading at or above $10.00 per public share, which may be at a time when the trading price of our Class A ordinary shares is below the exercise price of the warrants. The Company has established this redemption feature to provide the
      Company with the flexibility to redeem the warrants without the warrants having to reach the $18.00 per share threshold set forth above under “—Redemption of warrants when the price per Class A ordinary share equals
        or exceeds $18.00.” Holders choosing to exercise their warrants in connection with a redemption pursuant to this feature will, in effect, receive a number of shares for their warrants based on an option pricing model with a fixed volatility
      input as of the of our initial public offering. This redemption right provides the Company with an additional mechanism by which to redeem all of the outstanding warrants, and therefore have certainty as to our capital structure as the warrants would
      no longer be outstanding and would have been exercised or redeemed. The Company will be required to pay the applicable redemption price to warrant holders if the Company chooses to exercise this redemption right and it will allow the Company to
      quickly proceed with a redemption of the warrants if the Company determines it is in its best interest to do so. As such, the Company would redeem the warrants in this manner when the Company believes it is in our best interest to update its capital
      structure to remove the warrants and pay the redemption price to the warrant holders.

     

    
      
        

    

    As stated above, the Company can redeem the warrants when the Class A ordinary shares are trading at a price starting at $10.00, which is below the exercise price of $11.50, because it will provide certainty with respect
      to its capital structure and cash position while providing warrant holders with the opportunity to exercise their warrants on a cashless basis for the applicable number of shares. If the Company chooses to redeem the warrants when the Class A
      ordinary shares are trading at a price below the exercise price of the warrants, this could result in the warrant holders receiving fewer Class A ordinary shares than they would have received if they had chosen to wait to exercise their warrants for
      Class A ordinary shares if and when such Class A ordinary shares were trading at a price higher than the exercise price of $11.50.

     

    No fractional Class A ordinary shares will be issued upon exercise. If, upon exercise, a holder would be entitled to receive a fractional interest in a share, the Company will round down to the nearest whole number of
      the number of Class A ordinary shares to be issued to the holder. If, at the time of redemption, the warrants are exercisable for a security other than the Class A ordinary shares pursuant to the Warrant Agreement (for instance, if the Company are
      not the surviving company in our initial business combination), the warrants may be exercised for such security. At such time as the warrants become exercisable for a security other than the Class A ordinary shares, the Company (or surviving company)
      will use its commercially reasonable efforts to register under the Securities Act the security issuable upon the exercise of the warrants.

     

    Redemption procedures.

     

    A holder of a warrant may notify the Company in writing in the event it elects to be subject to a requirement that such holder will not have the right to exercise such warrant, to the extent that after giving effect to
      such exercise, such person (together with such person’s affiliates), to the warrant agent’s actual knowledge, would beneficially own in excess of 9.8% (or such other amount as a holder may specify) of the Class A ordinary shares issued and
      outstanding immediately after giving effect to such exercise.

     

    Anti-dilution Adjustments.

     

    If the number of outstanding Class A ordinary shares is increased by a capitalization or share dividend payable in Class A ordinary shares, or by a split-up of ordinary shares or other similar event, then, on the
      effective date of such capitalization or share dividend, split-up or similar event, the number of Class A ordinary shares issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding ordinary shares. A
      rights offering made to all or substantially all holders of ordinary shares entitling holders to purchase Class A ordinary shares at a price less than the “historical fair market value” (as defined below) will be deemed a share dividend of a number
      of Class A ordinary shares equal to the product of (i) the number of Class A ordinary shares actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable
      for Class A ordinary shares) and (ii) one minus the quotient of (x) the price per Class A ordinary share paid in such rights offering and (y) the historical fair market value. For these purposes, (i) if the rights offering is for securities
      convertible into or exercisable for Class A ordinary shares, in determining the price payable for Class A ordinary shares, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon
      exercise or conversion and (ii) “historical fair market value” means the volume weighted average price of Class A ordinary shares as reported during the ten trading day period ending on the trading day prior to the first date on which the Class A
      ordinary shares trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.

     

    
      
        

    

    In addition, if the Company, at any time while the warrants are outstanding and unexpired, pays a dividend or makes a distribution in cash, securities or other assets to all or substantially all of the holders of the
      Class A ordinary shares on account of such Class A ordinary shares (or other securities into which the warrants are convertible), other than (a) as described above, (b) any cash dividends or cash distributions which, when combined on a per share
      basis with all other cash dividends and cash distributions paid on the Class A ordinary shares during the 365-day period ending on the date of declaration of such dividend or distribution does not exceed $0.50 (as adjusted to appropriately reflect
      any other adjustments and excluding cash dividends or cash distributions that resulted in an adjustment to the exercise price or to the number of Class A ordinary shares issuable on exercise of each warrant) but only with respect to the amount of the
      aggregate cash dividends or cash distributions equal to or less than $0.50 per share, (c) to satisfy the redemption rights of the holders of Class A ordinary shares in connection with a proposed initial business combination, (d) to satisfy the
      redemption rights of the holders of Class A ordinary shares in connection with a shareholder vote to amend our Memorandum and Articles of Association (A) to modify the substance or timing of our obligation to provide holders of our Class A ordinary
      shares the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if the Company does not complete our initial business combination within 24 months from the closing of our
      initial public offering or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares or pre-initial business combination activity, or (e) in connection with the redemption of our public shares upon our
      failure to complete our initial business combination, then the warrant exercise price will be decreased, effective immediately after the effective date of such event, by the amount of cash and/or the fair market value of any securities or other
      assets paid on each Class A ordinary share in respect of such event.

     

    If the number of outstanding Class A ordinary shares is decreased by a consolidation, combination, reverse share split or reclassification of Class A ordinary shares or other similar event, then, on the effective date of
      such consolidation, combination, reverse share split, reclassification or similar event, the number of Class A ordinary shares issuable on exercise of each warrant will be decreased in proportion to such decrease in outstanding Class A ordinary
      shares.

     

    Whenever the number of Class A ordinary shares purchasable upon the exercise of the warrants is adjusted, as described above, the warrant exercise price will be adjusted by multiplying the warrant exercise price
      immediately prior to such adjustment by a fraction (x) the numerator of which will be the number of Class A ordinary shares purchasable upon the exercise of the warrants immediately prior to such adjustment and (y) the denominator of which will be
      the number of Class A ordinary shares so purchasable immediately thereafter.

     

    In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of our initial business combination at an issue price or
      effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by our board of directors and, in the case of any such issuance to our sponsor or its affiliates, without
      taking into account any founder shares held by our sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity
      proceeds, and interest thereon, available for the funding of our initial business combination on the date of the consummation of our initial business combination (net of redemptions), and (z) the volume weighted average trading price of our Class A
      ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates our initial business combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the
      warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described above under “—Redemption of
        warrants when the price per Class A ordinary share equals or exceeds $18.00” and “—Redemption of warrants when the price per Class A ordinary shares equals or exceeds $10.00” will be adjusted (to the
      nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described above under “—Redemption of warrants when the price per
        Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.

     

    
      
        

    

    In case of any reclassification or reorganization of the outstanding Class A ordinary shares (other than those described above or that solely affects the par value of such Class A ordinary shares), or in the case of any
      merger or consolidation of the Company with or into another corporation (other than a consolidation or merger in which the Company are the continuing corporation and that does not result in any reclassification or reorganization of our outstanding
      Class A ordinary shares), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of the Company as an entirety or substantially as an entirety in connection with which the Company are dissolved, the
      holders of the warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the warrants and in lieu of the Class A ordinary shares immediately theretofore purchasable and receivable
      upon the exercise of the rights represented thereby, the kind and amount of Class A ordinary shares or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution
      following any such sale or transfer, that the holder of the warrants would have received if such holder had exercised their warrants immediately prior to such event. However, if such holders were entitled to exercise a right of election as to the
      kind or amount of securities, cash or other assets receivable upon such consolidation or merger, then the kind and amount of securities, cash or other assets for which each warrant will become exercisable will be deemed to be the weighted average of
      the kind and amount received per share by such holders in such consolidation or merger that affirmatively make such election, and if a tender, exchange or redemption offer has been made to and accepted by such holders (other than a tender, exchange
      or redemption offer made by the company in connection with redemption rights held by shareholders of the company as provided for in our Memorandum and Articles of Association or as a result of the redemption of Class A ordinary shares by the company
      if a proposed initial business combination is presented to the shareholders of the company for approval) under circumstances in which, upon completion of such tender or exchange offer, the maker thereof, together with members of any group (within the
      meaning of Rule 13d-5(b)(1) under the Exchange Act) of which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under the Exchange Act) and any members of any such group of which any
      such affiliate or associate is a part, own beneficially (within the meaning of Rule 13d-3 under the Exchange Act) more than 50% of the issued and outstanding Class A ordinary shares, the holder of a warrant will be entitled to receive the highest
      amount of cash, securities or other property to which such holder would actually have been entitled as a shareholder if such warrant holder had exercised the warrant prior to the expiration of such tender or exchange offer, accepted such offer and
      all of the Class A ordinary shares held by such holder had been purchased pursuant to such tender or exchange offer, subject to adjustment (from and after the consummation of such tender or exchange offer) as nearly equivalent as possible to the
      adjustments provided for in the Warrant Agreement. If less than 70% of the consideration receivable by the holders of Class A ordinary shares in such a transaction is payable in the form of Class A ordinary shares in the successor entity that is
      listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the registered holder of the warrant properly exercises
      the warrant within thirty days following public disclosure of such transaction, the warrant exercise price will be reduced as specified in the Warrant Agreement based on the Black-Scholes value (as defined in the Warrant Agreement) of the warrant.
      The purpose of such exercise price reduction is to provide additional value to holders of the warrants when an extraordinary transaction occurs during the exercise period of the warrants pursuant to which the holders of the warrants otherwise do not
      receive the full potential value of the warrants.

     

    The warrants were issued in registered form under a Warrant Agreement. The Warrant Agreement provides that the terms of the warrants may be amended without the consent of any holder for the purpose of (i) curing any
      ambiguity or correct any mistake, including to conform the provisions of the Warrant Agreement to the description of the terms of the warrants and the Warrant Agreement set forth in our initial public offering, or defective provision (ii) amending
      the provisions relating to cash dividends on ordinary shares as contemplated by and in accordance with the Warrant Agreement or (iii) adding or changing any provisions with respect to matters or questions arising under the Warrant Agreement as the
      parties to the Warrant Agreement may deem necessary or desirable and that the parties deem to not adversely affect the rights of the registered holders of the warrants, provided that the approval by the holders of at least 65% of the then-outstanding
      public warrants is required to make any change that adversely affects the interests of the registered holders. Shareholders should review a copy of the Warrant Agreement, which is filed as an exhibit to the registration statement, for a complete
      description of the terms and conditions applicable to the warrants.

     

    The warrant holders do not have the rights or privileges of holders of ordinary shares and any voting rights until they exercise their warrants and receive Class A ordinary shares. After the issuance of Class A ordinary
      shares upon exercise of the warrants, each holder will be entitled to one vote for each share held of record on all matters to be voted on by shareholders.

     

    No fractional warrants will be issued upon separation of the units and only whole warrants will trade. If, upon exercise of the warrants, a holder would be entitled to receive a fractional interest in a share, the
      Company will, upon exercise, round down to the nearest whole number the number of Class A ordinary shares to be issued to the warrant holder.

     

    We have agreed that, subject to applicable law, any action, proceeding or claim against the Company arising out of or relating in any way to the Warrant Agreement will be brought and enforced in the courts of the State
      of New York or the United States District Court for the Southern District of New York, and the Company irrevocably submits to such jurisdiction, which jurisdiction will be the exclusive forum for any such action, proceeding or claim. This provision
      applies to claims under the Securities Act but does not apply to claims under the Exchange Act or any claim for which the federal district courts of the United States are the sole and exclusive forum.

     

    
      
        

    

    Private Placement Warrants

     

    Except as described below, the private placement warrants have terms and provisions that are identical to those of the warrants sold as part of the units in our initial public offering. The private placement warrants
      (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination (except pursuant to limited
      exceptions to our officers and directors and other persons or entities affiliated with the initial purchasers of the private placement warrants) and they will not be redeemable by the Company (except as described under “—Warrants—Public Shareholders’ Warrants—Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00”) so long as they are held by our sponsor or its permitted transferees (except as otherwise set forth
      herein). Our sponsor, or its permitted transferees, has the option to exercise the private placement warrants on a cashless basis. If the private placement warrants are held by holders other than our sponsor or its permitted transferees, the private
      placement warrants will be redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the units sold in our initial public offering. Any amendment to the terms of the private
      placement warrants or any provision of the Warrant Agreement with respect to the private placement warrants will require a vote of holders of at least 65% of the number of the then outstanding private placement warrants.

     

    Except as described above under “—Public Shareholders’ Warrants—Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00,” if holders of the
      private placement warrants elect to exercise them on a cashless basis, they would pay the exercise price by surrendering his, her or its warrants for that number of Class A ordinary shares equal to the quotient obtained by dividing (x) the product of
      the number of Class A ordinary shares underlying the warrants, multiplied by the excess of the “Sponsor fair market value” (defined below) over the exercise price of the warrants by (y) the Sponsor fair market value. For these purposes, the “Sponsor
      fair market value” means the average reported closing price of the Class A ordinary shares for the ten trading days ending on the third trading day prior to the date on which the notice of warrant exercise is sent to the warrant agent.

     

    In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors
      may, but are not obligated to, loan the Company funds as may be required. Up to $1,500,000 of such loans may be convertible into warrants of the post business combination entity at a price of $1.50 per warrant at the option of the lender. Such
      warrants would be identical to the private placement warrants.

     

    Dividends

     

    The Company has not paid any cash dividends on its ordinary shares to date and does not intend to pay cash dividends prior to the completion of our initial business combination. The payment of cash dividends in the
      future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition subsequent to completion of our initial business combination. The payment of any cash dividends subsequent to our initial business
      combination will be within the discretion of our board of directors at such time. Further, if the Company incurs any indebtedness in connection with a business combination, our ability to declare dividends may be limited by restrictive covenants the
      Company may agree to in connection therewith.

     

    
      
        

    

    Our Transfer Agent and Warrant Agent

     

    The transfer agent for our ordinary shares and warrant agent for our warrants is Continental Stock Transfer & Trust Company. The Company has agreed to indemnify Continental Stock Transfer & Trust Company in its
      roles as transfer agent and warrant agent, its agents and each of its shareholders, directors, officers and employees against all claims and losses that may arise out of acts performed or omitted for its activities in that capacity, except for any
      claims and losses due to any gross negligence or intentional misconduct of the indemnified person or entity.

     

    Our Memorandum and Articles of Association

     

    Our Memorandum and Articles of Association contains provisions designed to provide certain rights and protections relating to our initial public offering that apply to the Company until the completion of our initial
      business combination. These provisions cannot be amended without a special resolution under Cayman Islands law. As a matter of Cayman Islands law, a resolution is deemed to be a special resolution where it has been approved by either (i) the
      affirmative vote of at least two-thirds (or any higher threshold specified in a company’s articles of association) of a company’s shareholders entitled to vote and so voting at a shareholder meeting for which notice specifying the intention to
      propose the resolution as a special resolution has been given; or (ii) if so authorized by a company’s articles of association, by a unanimous written resolution of all of the company’s shareholders. Other than as described above, our Memorandum and
      Articles of Association provides that special resolutions must be approved either by at least two-thirds of our shareholders who attend and vote at a shareholder meeting of the company (i.e., the lowest threshold permissible under Cayman Islands
      law), or by a unanimous written resolution of all of our shareholders.

     

    Our sponsor and its permitted transferees, if any, who collectively beneficially own 20% of our ordinary shares, will participate in any vote to amend our Memorandum and Articles of Association and will have the
      discretion to vote in any manner they choose. Specifically, our Memorandum and Articles of Association provides, among other things, that:

     

    	

          	•	
            If the Company has not consummated an initial business combination within 24 months from the closing of our initial public offering, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as
              reasonably possible but no more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds
              held in the trust account and not previously released to the Company to pay our income taxes that were paid by the Company or are payable by us, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the
              then-outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible
              following such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii) to our obligations under Cayman Islands law to provide for
              claims of creditors and the requirements of other applicable law;

          

     

    	

          	•	
            Prior to or in connection with our initial business combination, the Company may not issue additional securities that would entitle the holders thereof to (i) receive funds from the trust account or (ii) vote as a class with our public
              shares (a) on our initial business combination or on any other proposal presented to shareholders prior to or in connection with the completion of an initial business combination or (b) to approve an amendment to our Memorandum and Articles
              of Association to (x) extend the time the Company has to consummate a business combination beyond 24 months from the closing of our initial public offering or (y) amend the foregoing provisions;

          

     

    	

          	•	
            Although the Company does not intend to enter into a business combination with a target business that is affiliated with our sponsor, Founders, our directors or our officers, the Company are not prohibited from doing so. In the event the
              Company enters into such a transaction, the Company, or a committee of independent directors, will obtain an opinion from an independent investment banking firm or another independent entity that commonly renders valuation opinions that such
              a business combination is fair to the Company from a financial point of view;

          

     

    	

          	•	
            If a shareholder vote on our initial business combination is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will
              offer to redeem our public shares pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, and will file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same
              financial and other information about our initial business combination and the redemption rights as is required under Regulation 14A of the Exchange Act;

          

     

    	

          	•	
            So long as our securities are then listed on the NYSE, our initial business combination must occur with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the trust account
              (excluding the amount of deferred underwriting discounts held in trust and taxes payable on the income earned on the trust account) at the time of the agreement to enter into our initial business combination;

          

     

    
      
        

    

    	

          	•	
            If our shareholders approve an amendment to our Memorandum and Articles of Association (A) that would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares
              redeemed in connection with our initial business combination or to redeem 100% of our public shares if the Company does not complete our initial business combination within 24 months from the closing of our initial public offering or (B) with
              respect to any other provision relating to the rights of holders of our Class A ordinary shares or pre-initial business combination activity, the Company will provide our public shareholders with the opportunity to redeem all or a portion of
              their ordinary shares upon such approval at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released
              to the Company to pay our income taxes, if any, divided by the number of the then-outstanding public shares, subject to the limitations described herein; and

          

     

    	

          	•	
            The Company will not effectuate our initial business combination solely with another blank check company or a similar company with nominal operations.

          

     

    In addition, our Memorandum and Articles of Association provides that under no circumstances will the Company redeem its public shares in an amount that would cause our net tangible assets to be less than $5,000,001.

     

    The Companies Act permits a company incorporated in the Cayman Islands to amend its memorandum and articles of association with the approval of a special resolution which requires the approval of the holders of at least
      two-thirds of such company’s issued and outstanding ordinary shares who attend and vote at a shareholder meeting or by way of unanimous written resolution. A company’s articles of association may specify that the approval of a higher majority is
      required but, provided the approval of the required majority is obtained, any Cayman Islands exempted company may amend its memorandum and articles of association regardless of whether its memorandum and articles of association provide otherwise.
      Accordingly, although the Company could amend any of the provisions relating to the our structure and business plan which are contained in our Memorandum and Articles of Association, we view all of these provisions as binding obligations to our
      shareholders and neither we, nor our officers or directors, will take any action to amend or waive any of these provisions unless we provide dissenting public shareholders with the opportunity to redeem their public shares.

     

    Registration and Shareholder Rights

     

    The holders of the founder shares, private placement warrants and any warrants that may be issued upon conversion of working capital loans (and any Class A ordinary shares issuable upon the exercise of the private
      placement warrants and warrants that may be issued upon conversion of working capital loans) are or will be entitled to registration rights pursuant to a registration and shareholder rights agreement to be signed prior to or on the effective date of
      our initial public offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights
      with respect to registration statements filed subsequent to our completion of our initial business combination. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed
      under the Securities Act to become effective until termination of the applicable lockup period, which occurs (i) in the case of the founder shares, as described in the following paragraph, and (ii) in the case of the private placement warrants and
      the respective Class A ordinary shares underlying such warrants, 30 days after the completion of our initial business combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

     

    Except as described herein, our sponsor and our directors and executive officers have agreed not to transfer, assign or sell their founder shares until the earliest of (A) one year after the completion of our initial
      business combination and (B) subsequent to our initial business combination, (x) if the closing price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations,
      recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or
      other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other
      agreements of our sponsor with respect to any founder shares.

     

    
      
        

    

    In addition, pursuant to the registration and shareholder rights agreement, our sponsor, upon and following consummation of an initial business combination, will be entitled to nominate three individuals for election to
      our board of directors, as long as our sponsor holds any securities covered by the registration and shareholder rights agreement.

     

    Listing of Securities

     

    Our units, Class A ordinary shares and warrants are listed on the NYSE under the symbols “ROSS.U”, “ROSS” and “ROSS WS”, respectively. The units will automatically separate into their component parts and will not be
      traded following the completion of our initial business combination.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}]]